SV Pharma
0767.715.111 · rovalta.com · 26/09/2026
SV Pharma
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBOSV Pharma is a Private limited company incorporated in 2021. Its main activity is: Activities of holding companies. Its registered office is in Ottignies-Louvain-la-Neuve.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0767.715.111
- Incorporation
- 30/04/2021
- Legal form
- Private limited company
- Registered office
- Avenue Reine Astrid 24
1340 Ottignies-Louvain-la-Neuve · WallonieSee on map - Contributed capital
- 50 000,00 €
- Latest accounts
- 30/06/2025
- Average workforce
- 0,0 ETP
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 6,4 k € | +133% | -19,4 k € | -2776% | -675 € | -108% | 8,9 k € |
| EBITDA | 5,4 k € | +127% | -19,9 k € | -1404% | -1,3 k € | -117% | 7,8 k € |
| Operating result | 3,1 k € | +114% | -22 k € | -545% | -3,4 k € | -158% | 5,8 k € |
| Net result | 61,2 k € | +61.3% | 37,9 k € | -47.2% | 71,8 k € | +11643% | -622,3 € |
| Balance sheet | |||||||
| Equity | 220,3 k € | +38.4% | 159,1 k € | +31.3% | 121,2 k € | +145% | 49,4 k € |
| Total assets | 814,5 k € | +4.6% | 778,4 k € | -1.1% | 787,3 k € | +2.9% | 765,4 k € |
| Cash | 8,1 k € | -8.5% | 8,8 k € | -37.1% | 14,1 k € | +415% | 2,7 k € |
| Debts | 594,2 k € | -4.0% | 619,2 k € | -7.0% | 666 k € | -7.0% | 716 k € |
| Other | |||||||
| Workforce | 0,0 ETP | 0,0 ETP | 0,0 ETP | – | |||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/20252 active
Active mandates
Other companies at this address
Avenue Reine Astrid 24 1340 Ottignies-Louvain-la-Neuve| Company | CBE no. |
|---|---|
| 1030.161.477 | |
Deep Trends Lab● Active | 1017.835.648 |
PHARMACIE D'OTTIGNIES● Active | 0442.281.693 |
SV Real Estate● Active | 0767.716.891 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/04/2021 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 15 months |
| Filing date | 17/01/2026 | 17/01/2025 | 12/01/2024 | 30/01/2023 |
| General meeting | 19/12/2025 | 20/12/2024 | 15/12/2023 | 16/12/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20252 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other04/05/2021RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202561,2 k €↑
- 2024Annual accounts 202437,9 k €↓
- 2023Annual accounts 202371,8 k €↑
- 2022Annual accounts 2022-622,3 €
- 30/04/2021IncorporationPrivate limited company